Task Force 9: Clinical Considerations for the Care of Athletes with Cardiac Channelopathies
Cardiac channelopathies, including long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, Brugada syndrome, and short QT syndrome, are heterogeneous conditions, which can lead to varying risks in athletes depending on their symptoms, disease severity, genotype, and therapies initiated. Historically, athletes with these conditions were excluded from participation with blanket restrictions, despite an absence of data. More recently, a number of studies have provided more scientific evidence to guide decision making and have been incorporated into these guidelines for athletes with cardiac channelopathies. Many athletes with these conditions may be supported in their decision to return to play as part of a shared decision-making model when they have been assessed, risk stratified, and appropriately treated by a specialist with expertise in these conditions.
Authors
- Eugene H. Chung (ORCID: https://orcid.org/0000-0002-7514-627X)
- Jonathan H. Kim (ORCID: https://orcid.org/0000-0001-5885-0284)
- Michael John Ackerman (ORCID: https://orcid.org/0000-0002-8011-3333)
- Aaron Leigh Baggish (ORCID: https://orcid.org/0000-0003-2042-1489)
- Mark S. Link
- Benjamin D. Levine
- Belinda Gray
- SUSAN ETHERIDGE
Institutions
- The University of Sydney (AU)
- Mayo Clinic (US)
- Harvard University (US)
- Emory University (US)
- Royal Prince Alfred Hospital (AU)
- Texas Health Dallas (US)
- Centre Hospitalier Universitaire Vaudois (CH)
- Massachusetts General Hospital (US)
- St. Luke's Children's Hospital (US)
- Institute for Exercise and Environmental Medicine (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Medicine & Science in Sports & Exercise
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1249/mss.0000000000004097
- Primary Topic
- Cardiovascular Effects of Exercise
- Type
- article
- Field-Weighted Citation Impact
- 0.00